Lupin gets 16 FDA nods, launches 11 products front
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...Read more
CSL marks a billion dollar in profits
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum A...Read more
CRO Survey 2014: CRO Landscape across APAC
Industry Insights | Analysis | By BioSpectrum Bureau | 3 Comment | 12 Nov, 2014
Singapore: Asia has earned the status of a fast growing market for clinical research due to its diverse population, fast...Read more
Cipla keeps the flag high for affordable drugs
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a gro...Read more
Samantha Su, Simranjit Singh: Finding skilled professionals is a challenge in Singapore
Industry Insights | Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...Read more
Dong-A Pharma diversifies portfolio to include biosimilars
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutica...Read more
Mindray Medical is set to penetrate the medtech market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing ...Read more
Sino Biopharma banks on quality manufacturing
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chin...Read more
Matt Kerr: Tough task ahead for APAC HR managers
Industry Insights | Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...Read more
China Resources Sanjiu looks ahead at acquisitions for growth
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is ...Read more
United Labs boosts production to meet high demand
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
The global life science industry has been facing a financial crunch and The United Laboratories too has felt the jolt....Read more
Industry Insights | Opinion | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2014
Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their o...Read more
North China Pharma integrates R&D strength in its system
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...Read more
Asia faces an acute skills gap challenge
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...Read more
Mindray goes on acquisition spree for strong portfolio
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2012
Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...Read more
Resmed dominates the niche sleep disorder market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...Read more
Sinopharm demonstrates king size growth, yet again
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...Read more
Cipla nurtures global vision for affordable drugs
Industry Insights | Analysis | By BioSpectrum Bureau | 2 Comment | 13 Jun, 2012
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...Read more